Fintel reports that on December 22, 2025, Canaccord Genuity maintained coverage of Caris Life Sciences (NasdaqGS:CAI) with a Hold recommendation.
Analyst Price Forecast Suggests 37.51% Upside
As of December 21, 2025, the average one-year price target for Caris Life Sciences is $38.42/share. The forecasts range from a low of $28.28 to a high of $47.25. The average price target represents an increase of 37.51% from its latest reported closing price of $27.94 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual non-GAAP EPS is -1.52.
What is the Fund Sentiment?
There are 267 funds or institutions reporting positions in Caris Life Sciences. This is an increase of 45 owner(s) or 20.27% in the last quarter. Average portfolio weight of all funds dedicated to CAI is 0.47%, an increase of 12.92%. Total shares owned by institutions increased in the last three months by 5.38% to 119,896K shares. 
The put/call ratio of CAI is 0.52, indicating a bullish outlook.
What are Other Shareholders Doing?
Sixth Street Partners Management Company holds 24,385K shares representing 8.64% ownership of the company. No change in the last quarter.
Coatue Management holds 10,142K shares representing 3.59% ownership of the company. No change in the last quarter.
T. Rowe Price Investment Management holds 8,026K shares representing 2.84% ownership of the company. In its prior filing, the firm reported owning 7,304K shares , representing an increase of 8.99%. The firm increased its portfolio allocation in CAI by 20.43% over the last quarter.
Braidwell holds 7,316K shares representing 2.59% ownership of the company. No change in the last quarter.
Price T Rowe Associates holds 6,925K shares representing 2.45% ownership of the company. In its prior filing, the firm reported owning 6,761K shares , representing an increase of 2.37%. The firm increased its portfolio allocation in CAI by 9.51% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
